Revealed together with Pfizer to a large audience during the recent PharmaLab (Germany) and Pharmig (UK) congresses, Merck’s automated bioburden testing solution has been awarded the ISPE Robotics Application of the Year Award for the Best QC Automation Application 2025. Each year, this prestigious award for outstanding innovations in pharmaceutical engineering and robotics recognizes excellence and groundbreaking achievements that shape the future of the pharmaceutical industry.
The jury praised the main features of this solution to ultimately enhance the efficiency and robustness of the testing process:
- High-throughput in bioburden testing, including complex protocols like pipetting, dilution, and rinsing
- Comprehensive traceability of records and integration into customers’ IT environment
- Robotics-friendly consumables to ensure high-level automated performance
- Adaptability to meet diverse customer requirements with flexible protocols and fluid handling options
This honor recognizes Merck’s commitment to developing automation and robotics solutions that aim to build the future of pharmaceutical QC.
Contact Merck experts to know more about this forward-looking, innovative solution
